國立虎尾科技大學 |

Microbiome and metabolome in diagnosis, therapy, and other strategic applications

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Microbiome and metabolome in diagnosis, therapy, and other strategic applications/ [edited by] Joel Faintuch, Salomao Faintuch.
other author:	Faintuch, Joel,
Published:	London, United Kingdom :Academic Press, : 2019.,
Description:	1 online resource (xxvii, 472 p.) :ill. :
Subject:	Microorganisms. -
Online resource:	https://www.sciencedirect.com/science/book/9780128152492
ISBN:	9780128152508 (electronic bk.)

Microbiome and metabolome in diagnosis, therapy, and other strategic applications
Microbiome and metabolome in diagnosis, therapy, and other strategic applications[electronic resource] /[edited by] Joel Faintuch, Salomao Faintuch. - London, United Kingdom :Academic Press,2019. - 1 online resource (xxvii, 472 p.) :ill.

Includes bibliographical references and index.

Germ-Free Animals as a Tool to Study Indigenous Microbiota -- Germ-Free Mouse Technology in Cardiovascular Research -- The Gut Microbiome Beyond the Bacteriome-The Neglected Role of Virome and Mycobiome in Health and Disease -- Techniques for Phenotyping the Gut Microbiota Metabolome -- Metabolomics Tools and Information Retrieval in Microbiome Hacking -- Laboratory Simulators of the Colon Microbiome -- Potential of Metabolomics to Breath Tests -- Metabolome and Microbiome From Infancy to Elderly -- The Oral Microbiome -- The Gastric Microbiome in Benign and Malignant Diseases -- The Human Vaginal Microbiome -- Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine -- Role of the Microbiome in Intestinal Barrier Function and Immune Defense -- The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric Surgery -- Use of Probiotics in Inflammatory Bowel Disease -- Current Status of Fecal Microbiota Transplantation -- Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials -- Current Options for Fecal Transplantation in Clostridium Difficile Infection -- Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy -- The Unknown Effect of Antibiotic-Induced Dysbiosis on the Gut Microbiota -- The Myth and Therapeautic Potentials of Postbiotics -- The Microbiome and Metabolome in Metabolic Syndrome -- The Gut Microbiota as a Therapeutic Approach for Obesity -- The Gut Microbiome After Bariatric Surgery -- Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management -- The Emerging Role of Microbiome-Gut-Brain Axis in Functional Gastrointestinal Disorders -- The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease -- The Microbiome and Metabolome in Alcoholic LIver Disease -- The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis -- Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis? -- The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease -- The Oral, Genital and Gut Microbiome in HIV Infection -- The Gut Microbiome in Autoimmune Diseases -- The Gut Microbiome and Metabolome in Multiple Sclerosis -- Connections Between Gut Microbiota and Bone Health -- The Gut Microbiome in Chronic Kidney Disease -- Dysbiosis in Benign and Malignant Diseases of the Exocrine Pancreas -- Importance of the Microbiome and the Metabolome in Cancer --The Microbiome in Graft Versus Host Disease -- Impact of the Gut Microbiome on Behavior and Emotions -- The Gut Microbiome in Vegetarians -- Metformin: A Candidate Drug to Control the Epidemic of Diabetes and Obesity by Way of Gut Microbiome Modification -- Deleterious Impact of Smog on the Intestinal Bacteria -- New-Generation Probiotics: Perspectives and Applications -- Fecal Microbiota Transfer and Inflammatory Bowel Disease: A Therapy or Risk? -- Precision Medicine: The Microbiome and Metabolome.

Microbiome and Metabolome in Diagnosis, Therapy, and Other Strategic Applications is the first book to simultaneously cover the microbiome and the metabolome in relevant clinical conditions. In a pioneering fashion, it addresses notonly the classic intestinal environment, but also the oral, gastric, lung, skin and vaginal microbiome that is in line with the latest investigations. Nonbacterial microbiomes, such as fungi and viruses are not overlooked, and the plasma microbiome is also discussed. As plasma, brain, placenta, tumor cells, and other sterile fluids and tissues, are increasingly recognized to potentially host a microbiome, albeit a limited one, this is a timely resource. The book's editors were fortunate to have the input of renowned collaborators from nearly all continents. This is truly an international effort that brings the latest in the field to students and professionals alike.

ISBN: 9780128152508 (electronic bk.)Subjects--Topical Terms:

600017
Microorganisms.
Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: QR46

Dewey Class. No.: 572/.472

National Library of Medicine Call No.: 2019 C-808

Microbiome and metabolome in diagnosis, therapy, and other strategic applications
LDR:05161cam a2200301 a 4500 001 1043057
006 m o d
007 cr cnu|||unuuu
008 211216s2019 enka gob 001 0 eng d
020 $a 9780128152508 (electronic bk.)
020 $a 0128152508 (electronic bk.)
020 $a 9780128152492
020 $a 0128152494
035 $a (OCoLC)1080938480
035 $a on1080938480
040 $a N$T $b eng $c N$T $d N$T $d EBLCP $d UKMGB $d OCLCF $d OPELS $d YDX $d TXM $d OCLCQ $d SFB $d S2H $d OCLCO $d UX1 $d OCL $d DKU
041 0 $a eng
050 4 $a QR46
060 4 $a 2019 C-808
060 4 $a QW 100
082 0 4 $a 572/.472 $2 23
245 0 0 $a Microbiome and metabolome in diagnosis, therapy, and other strategic applications $h [electronic resource] / $c [edited by] Joel Faintuch, Salomao Faintuch.
260 $a London, United Kingdom : $b Academic Press, $c 2019.
300 $a 1 online resource (xxvii, 472 p.) : $b ill.
504 $a Includes bibliographical references and index.
505 0 $a Germ-Free Animals as a Tool to Study Indigenous Microbiota -- Germ-Free Mouse Technology in Cardiovascular Research -- The Gut Microbiome Beyond the Bacteriome-The Neglected Role of Virome and Mycobiome in Health and Disease -- Techniques for Phenotyping the Gut Microbiota Metabolome -- Metabolomics Tools and Information Retrieval in Microbiome Hacking -- Laboratory Simulators of the Colon Microbiome -- Potential of Metabolomics to Breath Tests -- Metabolome and Microbiome From Infancy to Elderly -- The Oral Microbiome -- The Gastric Microbiome in Benign and Malignant Diseases -- The Human Vaginal Microbiome -- Bioactive Molecules of the Human Microbiome: Skin, Respiratory Tract, Intestine -- Role of the Microbiome in Intestinal Barrier Function and Immune Defense -- The Cross Talk Between Bile Acids and Intestinal Microbiota: Focus on Metabolic Diseases and Bariatric Surgery -- Use of Probiotics in Inflammatory Bowel Disease -- Current Status of Fecal Microbiota Transplantation -- Effects of Probiotics on Improvement of Metabolic Factors in Pregnant Women: A Metaanalysis of Randomized Placebo-Controlled Trials -- Current Options for Fecal Transplantation in Clostridium Difficile Infection -- Targeted Delivery of Bacteriophages to the Gastrointestinal Tract and Their Controlled Release: Unleashing the Therapeutic Potential of Phage Therapy -- The Unknown Effect of Antibiotic-Induced Dysbiosis on the Gut Microbiota -- The Myth and Therapeautic Potentials of Postbiotics -- The Microbiome and Metabolome in Metabolic Syndrome -- The Gut Microbiota as a Therapeutic Approach for Obesity -- The Gut Microbiome After Bariatric Surgery -- Gut Dysbiosis in Arterial Hypertension: A Candidate Therapeutic Target for Blood Pressure Management -- The Emerging Role of Microbiome-Gut-Brain Axis in Functional Gastrointestinal Disorders -- The Microbiome and Metabolome in Nonalcoholic Fatty Liver Disease -- The Microbiome and Metabolome in Alcoholic LIver Disease -- The Microbiome, Metabolome, and Proteome in Preterm Neonatal Sepsis -- Gut Microbiome in the Elderly Hospitalized Patient: A Marker of Disease and Prognosis? -- The Lung Microbiome, Metabolome, and Breath Volatolome in the Diagnosis of Pulmonary Disease -- The Oral, Genital and Gut Microbiome in HIV Infection -- The Gut Microbiome in Autoimmune Diseases -- The Gut Microbiome and Metabolome in Multiple Sclerosis -- Connections Between Gut Microbiota and Bone Health -- The Gut Microbiome in Chronic Kidney Disease -- Dysbiosis in Benign and Malignant Diseases of the Exocrine Pancreas -- Importance of the Microbiome and the Metabolome in Cancer --The Microbiome in Graft Versus Host Disease -- Impact of the Gut Microbiome on Behavior and Emotions -- The Gut Microbiome in Vegetarians -- Metformin: A Candidate Drug to Control the Epidemic of Diabetes and Obesity by Way of Gut Microbiome Modification -- Deleterious Impact of Smog on the Intestinal Bacteria -- New-Generation Probiotics: Perspectives and Applications -- Fecal Microbiota Transfer and Inflammatory Bowel Disease: A Therapy or Risk? -- Precision Medicine: The Microbiome and Metabolome.
520 $a Microbiome and Metabolome in Diagnosis, Therapy, and Other Strategic Applications is the first book to simultaneously cover the microbiome and the metabolome in relevant clinical conditions. In a pioneering fashion, it addresses notonly the classic intestinal environment, but also the oral, gastric, lung, skin and vaginal microbiome that is in line with the latest investigations. Nonbacterial microbiomes, such as fungi and viruses are not overlooked, and the plasma microbiome is also discussed. As plasma, brain, placenta, tumor cells, and other sterile fluids and tissues, are increasingly recognized to potentially host a microbiome, albeit a limited one, this is a timely resource. The book's editors were fortunate to have the input of renowned collaborators from nearly all continents. This is truly an international effort that brings the latest in the field to students and professionals alike.
588 $a Online resource; title from PDF title page (EBSCO, viewed January 10, 2019).
650 0 $a Microorganisms. $3 600017
650 0 $a Bacteria. $3 600016
650 0 $a Microorganisms $x Therapeutic use. $3 583267
650 0 $a Bacteria $x Therapeutic use. $3 1343919
650 0 $a Medical microbiology. $3 583124
650 0 $a Probiotics. $3 783841
650 7 $a SCIENCE $x Life Sciences $x Biochemistry. $2 bisacsh $3 812305
655 0 $a Electronic books. $2 local $3 554714
700 1 $a Faintuch, Joel, $e editor. $3 1343917
700 1 $a Faintuch, Salomão, $e editor. $3 1343918
856 4 0 $u https://www.sciencedirect.com/science/book/9780128152492